Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marsh

Showing results (591-600 of 654) with videos related to

Pageof 66
Sort By:
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Nature Communications|July 1, 2022
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodiesSun Jin Kim, Zhong Yao, Morgan C Marsh, et al.
Journal of Medicinal Chemistry|January 16, 2009
Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancerThomas D Penning, Gui-Dong Zhu, Viraj B Gandhi, et al.
Bone Marrow Transplantation|August 6, 2013
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow TransplantationJ C Marsh, R M Pearce, M B C Koh, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
Journal for Immunotherapy of Cancer|September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sourcesAndrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.
Blood|January 21, 2021
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trialJudith C Marsh, Simon J Stanworth, Laura A Pankhurst, et al.
Bioorganic & Medicinal Chemistry|January 2, 2007
4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitorsMark A Matulenko, Ernest S Paight, Robin R Frey, et al.
The Journal of Biological Chemistry|April 10, 1999
Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion moleculesC W Rittershaus, L J Thomas, D P Miller, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.
Pageof 66

Showing results (591-600 of 654) with videos related to

Sort By:
Pageof 66
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Nature Communications|July 1, 2022
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodiesSun Jin Kim, Zhong Yao, Morgan C Marsh, et al.
Journal of Medicinal Chemistry|January 16, 2009
Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancerThomas D Penning, Gui-Dong Zhu, Viraj B Gandhi, et al.
Bone Marrow Transplantation|August 6, 2013
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow TransplantationJ C Marsh, R M Pearce, M B C Koh, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
Journal for Immunotherapy of Cancer|September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sourcesAndrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.
Blood|January 21, 2021
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trialJudith C Marsh, Simon J Stanworth, Laura A Pankhurst, et al.
Bioorganic & Medicinal Chemistry|January 2, 2007
4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitorsMark A Matulenko, Ernest S Paight, Robin R Frey, et al.
The Journal of Biological Chemistry|April 10, 1999
Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion moleculesC W Rittershaus, L J Thomas, D P Miller, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.
Pageof 66